Evidence map›Paper›PMID 17146685›Full record

ArticleImmunogenetics2007

A novel strategy for defining haplotypes by selective depletion using restriction enzymes.

Anna S Smirnova, Kátia C Ferreira-Silva, Karina L Mine, Vinicius Andrade-Oliveira, Natalia Shulzhenko, Maria Gerbase-DeLima, Andrey Morgun

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anna S SmirnovaImmunogenetics Division, Pediatrics Department, Universidade Federal de São Paulo (UNIFESP-EPM), Rua Loefgreen, 1235, 04040-031 São Paulo, SP, Brazil. annsmile141@yahoo.com
Kátia C Ferreira-Silva
Karina L Mine
Vinicius Andrade-Oliveira
Natalia Shulzhenko
Maria Gerbase-DeLima
Andrey Morgun
Universidade Federal de São Paulo · BRNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various single nucleotide polymorphisms (SNPs) have been investigated regarding association with gene expression levels or human diseases. Although different SNPs within one gene are frequently analyzed individually, it is highly probable that in the majority of the cases, a precise combination of SNP alleles, i.e., haplotype, determines a functional trait. Methods commonly used for haplotype determination, involving studies in families, cloning, or somatic cell hybrids, are expensive and time-consuming. We herein suggest a novel and simple strategy for haplotype determination, involving selective haplotype depletion with a restriction enzyme, followed by sequencing. We studied 11 LTA gene polymorphisms in 102 Brazilian individuals, and we applied this novel methodology for haplotyping 67 out of 70 LTA heterozygous individuals. We concluded that the method is rapid and efficient, and, as it includes only simple and widespread-used techniques, it could be used in most of the laboratories without further investment in equipments. The wider usage of haplotyping could be important to clarify contradictory results frequently observed among studies that focus on a single SNP.

Indexed as

Polymorphism, Single NucleotideAllelesBrazilDNA Restriction EnzymesGenetic TestingGenotypeHaplotypesHumansLymphotoxin-alphaPolymerase Chain ReactionDNA Restriction EnzymesLymphotoxin-alpha

Identifiers

PMID17146685
OpenAlexW2069785010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.